Evidence map›Paper›PMID 28250025›Full record

ArticleJournal of lipid research2017

Synthesis of apo-13- and apo-15-lycopenoids, cleavage products of lycopene that are retinoic acid antagonists.

Sureshbabu Narayanasamy, Jian Sun, Ryan E Pavlovicz, Abdulkerim Eroglu, Cassandra E Rush, Benjamin D Sunkel, Chenglong Li, Earl H Harrison, Robert W Curley

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Analytical chemistry · 2022
    Article
  7. Review
  8. Review
  9. Carotenoid metabolism at the intestinal barrier.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2020
    Review
  10. Review
  11. Article
  12. Apocarotenoids: Emerging Roles in Mammals.Annual review of nutrition · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Sureshbabu NarayanasamyDepartment of Human Sciences, The Ohio State University, Columbus, OH 43210.
Jian SunDepartment of Human Sciences, The Ohio State University, Columbus, OH 43210.
Ryan E PavloviczBiophysics Graduate Program, The Ohio State University, Columbus, OH 43210.
Abdulkerim ErogluOhio State Biochemistry Program, The Ohio State University, Columbus, OH 43210.
Cassandra E RushDivision of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210.
Benjamin D SunkelOhio State Biochemistry Program, The Ohio State University, Columbus, OH 43210.
Chenglong LiDivision of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210.
Earl H HarrisonDepartment of Human Sciences, The Ohio State University, Columbus, OH 43210 Curley.1@osu.edu Harrison.304@osu.edu.
Robert W CurleyDivision of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210 Curley.1@osu.edu Harrison.304@osu.edu.
The Ohio State University · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
DIETARY CAROTENOIDS--TRANSPORT IN HUMAN PLASMAR01HL049879 · NHLBI · U.S. DEPARTMENT OF AGRICULTURE · PI HARRISON, EARL HOWARD · 1994 to 2013
$2.5M
Vitamin A Homeostasis: Retinyl Ester StoresR01DK101251 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BLANER, WILLIAM S, HARRISON, EARL HOWARD · 2016 to 2018
$1.4M
NCI NIH HHS P30 CA016058NHLBI NIH HHS R01 HL049879NIDDK NIH HHS R01 DK101251
6 · The paper itself

Abstract

Consumption of the tomato carotenoid, lycopene, has been associated with favorable health benefits. Some of lycopene's biological activity may be due to metabolites resulting from cleavage of the lycopene molecule. Because of their structural similarity to the retinoic acid receptor (RAR) antagonist, β-apo-13-carotenone, the "first half" putative oxidative cleavage products of the symmetrical lycopene have been synthesized. All transformations proceed in moderate to good yield and some with high stereochemical integrity allowing ready access to these otherwise difficult to obtain terpenoids. In particular, the methods described allow ready access to the

Indexed as

CarotenoidsChemistry Techniques, SyntheticGene Expression RegulationHep G2 CellsHumansLycopeneMolecular Docking SimulationProtein ConformationReceptors, Retinoic AcidCarotenoidsLycopeneReceptors, Retinoic Acidapolipoprotein-13-lycopenoneapolycopenoidschemical synthesisdiet and dietary lipidsgene expressionnuclear receptorsretinoic acid receptor antagonistretinoids/vitamin A

Identifiers

PMID28250025
PMCPMC5408601
OpenAlexW2592794247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.